NEWS EMA Publishes New Lupus Guideline Intended to Spur Development of New Therapies

by Chris Burton

NEWS EMA Publishes New Lupus Guideline Intended to Spur Development of New Therapies

In a statement released on 5 March 2013, EMA explained that while advancements in care have dramatically reduce mortalities and morbidities associated with the disease, “Many patients still have incompletely controlled disease and progress to end-stage organ failure.”

“Therefore, there is a need for the development of effective medicines to treat this condition,” the agency argued.